Robert R. Banks Jr. - 14 May 2024 Form 4 Insider Report for NEPHROS INC (NEPH)

Role
President and CEO, Director
Signature
/s/ Edward Peilen as attorney-in-fact for Robert R. Banks, Jr. pursuant to power of attorney previously filed.
Issuer symbol
NEPH
Transactions as of
14 May 2024
Net transactions value
+$112,050
Form type
4
Filing time
16 May 2024, 16:49:44 UTC
Previous filing
11 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEPH Common Stock Purchase $112,050 +50,000 +250% $2.24 70,000 16 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEPH Stock Option (right to buy) Award $0 +10,406 $0.000000 10,406 14 May 2024 Common Stock 10,406 $2.14 Direct F3
holding NEPH Stock Option (right to buy) 357,165 14 May 2024 Common Stock 357,165 $1.44 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.10 to $2.25, inclusive. The reporting person undertakes to provide Nephros Inc., any security holder of Nephros Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the set range set forth in this footnote.
F2 Options to purchase 89,291 shares vest on 5/5/24 and options to purchase 267,874 shares vest quarterly in 12 equal amounts commencing on 8/5/24.
F3 Options to purchase 2,601 shares vest on 5/14/25 and options to purchase the remaining 7,805 shares vest quarterly in 12 equal amounts commencing on 8/14/25.